A novel deletion creating a new terminal exon of the dihydrolipoyl transacylase gene is a founder mutation of Filipino maple syrup urine disease

Mol Genet Metab. 2004 Feb;81(2):100-4. doi: 10.1016/j.ymgme.2003.10.006.

Abstract

Maple syrup urine disease (MSUD) is a rare, autosomal-recessive disorder of branched-chain amino-acid metabolism. In the Philippines, many MSUD cases have been diagnosed clinically. Here, molecular analysis of the dihydrolipoyl transacylase (E2) gene was done in 13 unrelated families from the Philippines. A novel deletion spanning 4.1 kb of intron 10 and 601 bp of exon 11, caused by non-homologous recombination between an L1 repeat in intron 10 and an Alu repeat in exon 11, was found in 8 out of 13 families, with 5 of them being homozygous for the mutation, implicating it as a founder mutation of Filipino MSUD. The resulting mutant E2 mRNA contains a 239-bp insertion after exon 10, thereby producing a new terminal exon. Large-scale population screening of the deletion revealed that one carrier of the mutation was identified in 100 normal Filipinos. These findings suggest that a limited number of mutations might underlie MSUD in the Filipino population, potentially facilitating prenatal diagnosis and carrier detection of MSUD in this group.

MeSH terms

  • 3' Untranslated Regions / genetics
  • Acetyltransferases / genetics*
  • Base Sequence*
  • Dihydrolipoyllysine-Residue Acetyltransferase
  • Exons*
  • Founder Effect
  • Humans
  • Maple Syrup Urine Disease / genetics*
  • Models, Genetic
  • Mutation*
  • Philippines
  • Pyruvate Dehydrogenase Complex / genetics*
  • Sequence Deletion*

Substances

  • 3' Untranslated Regions
  • Pyruvate Dehydrogenase Complex
  • Acetyltransferases
  • Dihydrolipoyllysine-Residue Acetyltransferase